Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CP-690,550 phase 2 trial in moderate to severe ulcerative colitis
2008-004564-40Phase 2Completed
- Sponsor
- Pfizer
- Start
- Sep 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in autoimmune colitis comparing CP-690,550 with Placebo (2 arms). Primary endpoint: Clinical response at Week 8. Started Sep 2008; status: completed.
02
Drugs
03
Conditions
autoimmune colitis
Beyond the preview
Go deeper on 2008-004564-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-004564-40.